ClinicalTrials.Veeva

Menu

Swept Source OCT Imaging With the DREAM VG-OCT

R

Robert T. Chang, MD

Status

Completed

Conditions

Myopia
Glaucoma
Eye Diseases

Treatments

Device: DREAM OCT

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The Intalight Dream OCT is the first combo anterior plus posterior device to perform both OCT and OCT-A at depth of 16mm. This is especially useful in patient who are very nearsighted as it allows us to image all in one frame. The intention of this study is to see how the images differ on the same patients when compared to the Cirrus OCT and to test for the repeatability of the images on a single day.

Enrollment

154 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age greater than or equal to 18
  • Myopes with a current or previously documented spherical equivalent refraction < -4D
  • At least half of the subjects should have had at least one Cirrus OCT RNFL and macula performed as well as a Humphrey visual field performed in those with OCT abnormalities

Exclusion criteria

  • Unable to comply with study imaging
  • unclear ocular media
  • Participant has, in the opinion of the investigator, any physical or mental condition that would affect the participation in the study or may interfere with the study procedures, evaluations and outcome assessments.

Trial design

154 participants in 1 patient group

DREAM OCT
Description:
All 50 patients will have both eyes (if able) imaged, 3 times, on the same day during their clinic visit.
Treatment:
Device: DREAM OCT

Trial contacts and locations

1

Loading...

Central trial contact

Study Team

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems